首页> 外文OA文献 >Psychometric properties of FACIT-Fatigue in systemic lupus erythematosus: a pooled analysis of three phase 3 randomised, double-blind, parallel-group controlled studies (BLISS-SC, BLISS-52, BLISS-76)

【2h】

Psychometric properties of FACIT-Fatigue in systemic lupus erythematosus: a pooled analysis of three phase 3 randomised, double-blind, parallel-group controlled studies (BLISS-SC, BLISS-52, BLISS-76)

机译：Systemic Lupus红斑狼疮性疲劳的心理测量性能：三相3阶段随机，双盲，并联控制研究的汇总分析（Bliss-SC，Bliss-52，Bliss-76）

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Regina Rendas-Baum; Nishtha Baranwal; Ashish V. Joshi; Josephine Park; Mark Kosinski;
展开▼
作者单位

展开▼
年度 2021
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献

1. Psychometric properties of FACIT-Fatigue in systemic lupus erythematosus: a pooled analysis of three phase 3 randomised, double-blind, parallel-group controlled studies (BLISS-SC, BLISS-52, BLISS-76) [J] . Rendas-Baum Regina, Baranwal Nishtha, Joshi Ashish V., Journal of Patient-Reported Outcomes . 2021,第1期

机译：Systemic Lupus狼疮性疲劳的心理测量特性：三相3阶段随机，双盲，平行组对照研究的汇总分析（Bliss-SC，Bliss-52，Bliss-76）
2. Efficacy and safety of ustekinumab, an IL-12 and IL-23 inhibitor, in patients with active systemic lupus erythematosus: results of a multicentre, double-blind, phase 2, randomised, controlled study [J] . Ronald F van Vollenhoven, Bevra H Hahn, George C Tsokos, The Lancet . 2018,第10155期

机译：Ustekinumab，IL-12和IL-23抑制剂的疗效和安全性，活性全身性狼疮性红斑狼疮：多期，双盲，第2期，随机，受控研究的结果
3. Efficacy and safety of subcutaneous tabalumab, a monoclonal antibody to B-cell activating factor, in patients with systemic lupus erythematosus: results from ILLUMINATE-2, a 52-week, phase III, multicentre, randomised, double-blind, placebo-controlled study [J] . Merrill J. T., van Vollenhoven R. F., Buyon J. P., Annals of the Rheumatic Diseases: A Journal of Clinical Rheumatology and Connective Tissue Research . 2016,第2期

机译：系统性红斑狼疮患者皮下注射talalumab（一种针对B细胞活化因子的单克隆抗体）的疗效和安全性：ILLUMINATE-2的一项52周，III期，多中心，随机，双盲，安慰剂对照研究
4. A Phase 1B, Double-blind, Placebo-controlled, Parallel-group, Multi-dose Study of the Pharmacodynamics of NGM282 on Colonic Transit, Bile Acid Homeostasis and Fecal Fat in Subjects with Functional Constipation [D] . Oduyebo, Ibironke. 2018

机译：1B，双盲，安慰剂控制，并行组，NGM282对结肠转运，胆汁酸痛和患者功能性便秘的粪便脂肪的药物动力学的多剂量研究
5. Psychometric properties of FACIT-Fatigue in systemic lupus erythematosus: a pooled analysis of three phase 3 randomised double-blind parallel-group controlled studies (BLISS-SC BLISS-52 BLISS-76) [O] . Regina Rendas-Baum, Nishtha Baranwal, Ashish V. Joshi, 2021

机译：Systemic Lupus红斑狼疮性疲劳的心理测量性能：三相3阶段随机双盲并联控制研究的汇总分析（Bliss-SCBliss-52Bliss-76）
6. Phase III, multicentre, randomised, double-blind, placebo-controlled, 104-week study of subcutaneous belimumab administered in combination with rituximab in adults with systemic lupus erythematosus (SLE): BLISS-BELIEVE study protocol [O] . Y K Onno Teng, Ian N Bruce, Betty Diamond, 2019

机译：III期，多期，随机，双盲，安慰剂控制的，对皮下信仰的104周的研究与RITUXIMAB在具有全身性狼疮红肿（SLE）的成人中（SLE）的组合给药：Bliss-right研究方案

Psychometric properties of FACIT-Fatigue in systemic lupus erythematosus: a pooled analysis of three phase 3 randomised, double-blind, parallel-group controlled studies (BLISS-SC, BLISS-52, BLISS-76)

著录项

引文网络

相似文献

相关主题

期刊订阅